Isoniazid preventive therapy for children in sub-Saharan Africa

Lancet Respir Med. 2019 Mar;7(3):197-199. doi: 10.1016/S2213-2600(19)30037-2.
No abstract available

MeSH terms

  • Africa South of the Sahara / epidemiology
  • Antitubercular Agents / therapeutic use
  • Chemoprevention / methods*
  • Child
  • Disease Progression
  • HIV Infections / epidemiology
  • Humans
  • Isoniazid / therapeutic use*
  • Latent Tuberculosis* / epidemiology
  • Latent Tuberculosis* / therapy
  • Needs Assessment*
  • Patient Care Management / organization & administration
  • Patient Care Management / standards
  • Practice Guidelines as Topic / standards*
  • Risk Factors
  • World Health Organization

Substances

  • Antitubercular Agents
  • Isoniazid